Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Drolet

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Adriamycin and cis-platinum in advanced ovarian cancerA de Gramont, Y Drolet, A Lavoie, et al.
L'Union Medicale Du Canada|July 1, 1984
[Initial chemotherapy of advanced cancer of the ovary. Comparison of the results obtained using the combination of adriamycin and cisplatin and the earlier therapeutic modalities]A de Gramont, Y Drolet, A Lavoie, et al.
L'Union Medicale Du Canada|April 1, 1985
[Leukemias secondary to cytotoxic therapy. Study of 29 cases in Quebec and Montreal]A de Gramont, M Bergeron, Y Drolet, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1986
[Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)]A de Gramont, Y Drolet, C Louvet, et al.
Oncology|January 1, 1986
Acute leukemia after treatment for ovarian cancer. Report of four cases and review of the literatureA De Gramont, P Remes, M Krulik, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patientsA de Gramont, Y Drolet, C Varette, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1989
[Prognosis in ovarian cancer as a function of the results of the second-look laparatomy]C Varette, A de Gramont, C Louvet, et al.
Cancer|January 15, 1987
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's diseaseA de Gramont, C Louvet, M Krulik, et al.
Cancer|August 1, 1986
Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 casesA De Gramont, C Louvet, M Krulik, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1997
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinomaE Raymond, Y Drolet, L Marpeau, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Adriamycin and cis-platinum in advanced ovarian cancerA de Gramont, Y Drolet, A Lavoie, et al.
L'Union Medicale Du Canada|July 1, 1984
[Initial chemotherapy of advanced cancer of the ovary. Comparison of the results obtained using the combination of adriamycin and cisplatin and the earlier therapeutic modalities]A de Gramont, Y Drolet, A Lavoie, et al.
L'Union Medicale Du Canada|April 1, 1985
[Leukemias secondary to cytotoxic therapy. Study of 29 cases in Quebec and Montreal]A de Gramont, M Bergeron, Y Drolet, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1986
[Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)]A de Gramont, Y Drolet, C Louvet, et al.
Oncology|January 1, 1986
Acute leukemia after treatment for ovarian cancer. Report of four cases and review of the literatureA De Gramont, P Remes, M Krulik, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patientsA de Gramont, Y Drolet, C Varette, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1989
[Prognosis in ovarian cancer as a function of the results of the second-look laparatomy]C Varette, A de Gramont, C Louvet, et al.
Cancer|January 15, 1987
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's diseaseA de Gramont, C Louvet, M Krulik, et al.
Cancer|August 1, 1986
Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 casesA De Gramont, C Louvet, M Krulik, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1997
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinomaE Raymond, Y Drolet, L Marpeau, et al.
Pageof 2